PREVENTION OF ROTAVIRUS INFECTION: THE WAY OF EXPANSION OF THE REGIONAL VACCINATION PROGRAM IN TYUMEN REGION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The evaluation of the epidemic process of AII in the Tyumen region was carried out according to official records and reports of Rospotrebnadzor Department in the Tyumen region from 1993 to 2014. Given the highly contagiosity of rotavirus infection (RVI), prevention program of RVI vaccination was developed in order to reduce the incidence of RVI in infants and prevention of mortality. Specific prophylaxis of RVI using pentavalent RotaTeq live vaccine in combination with other vaccines recommended by regional immunization schedule was carried out in 1000 children. Comparative analysis of RVI incidence and in 1-2-year-old children in children’s polyclinics, where prevention program was implemented, showed a downward trend during the period of seasonal pick of infection. High safety and efficacy profile of immunization program with RotaTeq is demonstrated.

Full Text

Restricted Access

About the authors

O. A Rychkova

FSBEI HE “Tyumen State Medical University" of RMH

MD, Head at the Department of childhood illness medical faculty with the course of immunology and allergology Tyumen

N. V Kazakevich

Department of Health in Tyumen Region

O. A Dubinina

Rospotrebnadzor Department in Tyumen Region

G. V Sharukho

Rospotrebnadzor Department in Tyumen Region

M. A Kurbatsaya

Rospotrebnadzor Department in Tyumen Region

G. N Ivanova

SBHCI TR “Regional Clinical Hospital of Infectious Diseases"

Tyumen

A. T Podkolzin

FBIS “Central SRI of Epidemiology" of Rospotrebnadzor

Moscow

S. N Suglobova

MMAI “City Polyclinic № 8»

Tyumen

N. P Sennikova

MMAI “City Polyclinic № 5»

Tyumen

T. P Lylova

MMAI “City Polyclinic № 13"

Tyumen

M. P Kulichenko

Department of Health Administration of Tyumen

References

  1. Иванова Г.Н. Эпидемиологические аспекты и этиологическая расшифровка острых кишечных инфекций вирусной этиологии (по материалам Тюменской области), Дисс. канд. мед. наук. 2013.
  2. Staat M.A., Payne D.C., Donauer S., Weinberg G.A., Edwards K.M., Szilagyi P.G., Griffin M.R., Hall C.B., Curns A.T., Gentsch J.R., Salisbury S., Fairbrother G., Parashar U.D. Effectiveness of the pentavalent rotavirus vaccine against severe disease. Pediatrics. 2011;128(2):267-74.
  3. Wang F.T., Mast C.T., Glass R.J., Loughlin J., Seeger J.D. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010;125(2):e208-13.
  4. Cortese M.M., Parashar U.D. Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25.
  5. Vesikary T., van Damme P., Giaquinto C., Dagan R., Guarino A., Szajewska H., Usonis V. European Society for prdiatric infectious diseases consensus recommendations for rotavirus vaccination in Europe. Pediatr. Inf. Dis. J. 2015;34(6):635-43.
  6. Ротавирусные вакцины. Документ по позиции ВОЗ - январь 2013 г. 1 февраля 2013 г., 88-й год, № 5. Еженедельный эпидемиологический бюллетень. 2013;88:49-64. URL: http:// www.who.int/wer

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies